can semaglutide cause tinnitus ringing in the ears The Unwanted Beat of Pulsatile Can Semaglutide Cause Headaches? Frequency

Semaglutide works by binding to GLP-1 receptors

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities, and in adolescents aged 12 years and older with obesity

The brand publishes structured pricing tiers, a 28-day refund window with two specific qualifying circumstances, a Telehealth Informed Consent process, a HIPAA Notice of Privacy Practices, exclusionary clinical criteria managed by CareValidate Health, and explicit language stating that compounded GLP-1 medications are not FDA-approved

It is injectable and compounded only, no oral option and no brand-name Wegovy, and there are no refunds once medication has shipped

This ensures that weight loss outcomes are achieved within established safety parameters rather than through accelerated dosing

A quick supply sanity-check: a 5 mg vial reconstituted to 2.5 mg/mL holds 20 0.25 mg doses, but because the dose climbs each month, one 5 mg vial does not cover a full titration